{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,3,2]],"date-time":"2026-03-02T14:35:51Z","timestamp":1772462151736,"version":"3.50.1"},"reference-count":17,"publisher":"Ovid Technologies (Wolters Kluwer Health)","issue":"1","content-domain":{"domain":["lww.com","ovid.com"],"crossmark-restriction":true},"short-container-title":[],"published-print":{"date-parts":[[2022,1]]},"abstract":"<jats:sec>\n            <jats:title>OBJECTIVES:<\/jats:title>\n            <jats:p>To describe the use and outcomes of extracorporeal membrane oxygenation support among children with immune-mediated conditions.<\/jats:p>\n          <\/jats:sec>\n          <jats:sec>\n            <jats:title>DESIGN:<\/jats:title>\n            <jats:p>Retrospective cohort study.<\/jats:p>\n          <\/jats:sec>\n          <jats:sec>\n            <jats:title>SETTING:<\/jats:title>\n            <jats:p>The Extracorporeal Life Support Organization registry.<\/jats:p>\n          <\/jats:sec>\n          <jats:sec>\n            <jats:title>PATIENTS:<\/jats:title>\n            <jats:p>Patients 1 month to 18 years old with <jats:italic toggle=\"yes\">International Classification of Diseases<\/jats:italic>, 9th Edition and <jats:italic toggle=\"yes\">International Classification of Diseases<\/jats:italic>, 10th Edition codes for immune-mediated conditions from 1989 to 2018.<\/jats:p>\n          <\/jats:sec>\n          <jats:sec>\n            <jats:title>INTERVENTIONS:<\/jats:title>\n            <jats:p>None.<\/jats:p>\n          <\/jats:sec>\n          <jats:sec>\n            <jats:title>MEASUREMENTS AND MAIN RESULTS:<\/jats:title>\n            <jats:p>During the study period, 207 patients with an immune-mediated condition received extracorporeal membrane oxygenation, and 50% survived to discharge. Most patients (63%) received extracorporeal membrane oxygenation for respiratory support with 53% survival, 21% received cardiac support (55% survival), and 15% received extracorporeal cardiopulmonary resuscitation (34% survival). The most common diagnosis among nonsurvivors was hemophagocytic lymphohistiocytosis\/macrophage activation syndrome with 37% survival. Patients with juvenile idiopathic arthritis (23%) and dermatomyositis (25%) had the lowest survival. Nonsurvivors had a higher frequency of infections, neurologic complications, and renal replacement therapy use. Use of preextracorporeal membrane oxygenation corticosteroids was associated with mortality.<\/jats:p>\n          <\/jats:sec>\n          <jats:sec>\n            <jats:title>CONCLUSIONS:<\/jats:title>\n            <jats:p>Children with immune-mediated conditions can be successfully supported with extracorporeal membrane oxygenation. Extracorporeal membrane oxygenation use has increased over time, and survival varies considerably by diagnosis.<\/jats:p>\n          <\/jats:sec>","DOI":"10.1097\/pcc.0000000000002801","type":"journal-article","created":{"date-parts":[[2021,7,15]],"date-time":"2021-07-15T01:00:28Z","timestamp":1626310828000},"page":"e60-e65","update-policy":"https:\/\/doi.org\/10.1097\/lww.0000000000001000","source":"Crossref","is-referenced-by-count":5,"title":["The Use of Extracorporeal Life Support in Children With Immune-Mediated Diseases"],"prefix":"10.1097","volume":"23","author":[{"given":"Jessica A.","family":"Barreto","sequence":"first","affiliation":[{"name":"Department of Pediatrics, Division of Critical Care Medicine, Seattle Children\u2019s Hospital, University of Washington School of Medicine, Seattle, WA."}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Amit","family":"Mehta","sequence":"additional","affiliation":[{"name":"Department of Pediatrics, Oregon Health and Sciences University, Portland, OR."}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Ravi R.","family":"Thiagarajan","sequence":"additional","affiliation":[{"name":"Department of Cardiology, Children\u2019s Hospital, Boston, Department of Pediatrics, Harvard Medical School, Boston, MA."}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Kristen N.","family":"Hayward","sequence":"additional","affiliation":[{"name":"Department of Pediatrics, Division of Rheumatology, Seattle Children\u2019s Hospital, University of Washington School of Medicine, Seattle, WA."}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Adrian","family":"Brogan","sequence":"additional","affiliation":[{"name":"University of Washington, Seattle, WA."}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Thomas V.","family":"Brogan","sequence":"additional","affiliation":[{"name":"Department of Pediatrics, Division of Critical Care Medicine, Seattle Children\u2019s Hospital, University of Washington School of Medicine, Seattle, WA."}],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"276","published-online":{"date-parts":[[2021,7,14]]},"reference":[{"key":"R1-20250502","doi-asserted-by":"crossref","first-page":"119","DOI":"10.1016\/S1568-9972(03)00006-5","article-title":"The epidemiology of autoimmune diseases.","volume":"2","author":"Cooper","year":"2003","journal-title":"Autoimmun Rev"},{"key":"R2-20250502","doi-asserted-by":"crossref","first-page":"e181","DOI":"10.1097\/PCC.0b013e318238955c","article-title":"Pediatric rheumatic disease in the intensive care unit: Lessons learned from 15 years of experience in a tertiary care pediatric hospital.","volume":"13","author":"Radhakrishna","year":"2012","journal-title":"Pediatr Crit Care Med"},{"key":"R3-20250502","doi-asserted-by":"crossref","first-page":"341","DOI":"10.1111\/j.1445-5994.2012.02720.x","article-title":"Extracorporeal membrane oxygenation with plasma exchange in a patient with alveolar haemorrhage secondary to Wegener\u2019s granulomatosis.","volume":"42","author":"Barnes","year":"2012","journal-title":"Intern Med J"},{"key":"R4-20250502","doi-asserted-by":"crossref","first-page":"104","DOI":"10.1177\/0885066612464335","article-title":"Systemic lupus-induced diffuse alveolar hemorrhage treated with extracorporeal membrane oxygenation: A case report and review of the literature.","volume":"29","author":"Patel","year":"2014","journal-title":"J Intensive Care Med"},{"key":"R5-20250502","doi-asserted-by":"crossref","first-page":"e6024","DOI":"10.1097\/MD.0000000000006024","article-title":"Granulomatosis with polyangiitis presenting with diffuse alveolar hemorrhage requiring extracorporeal membrane oxygenation with rapid multiorgan relapse: A case report.","volume":"96","author":"Vanoli","year":"2017","journal-title":"Medicine (Baltimore)"},{"key":"R6-20250502","doi-asserted-by":"crossref","first-page":"526","DOI":"10.1007\/s00467-004-1724-5","article-title":"Extra corporeal membrane oxygenation and plasmapheresis for pulmonary hemorrhage in microscopic polyangiitis.","volume":"20","author":"Agarwal","year":"2005","journal-title":"Pediatr Nephrol"},{"key":"R7-20250502","doi-asserted-by":"crossref","first-page":"e10946","DOI":"10.1097\/MD.0000000000010946","article-title":"Combined usage of extracorporeal membrane oxygenation and double filtration plasmapheresis in amyopathic dermatomyositis patient with severe interstitial lung disease: A case report.","volume":"97","author":"Huang","year":"2018","journal-title":"Medicine (Baltimore)"},{"key":"R8-20250502","doi-asserted-by":"crossref","first-page":"1663","DOI":"10.1007\/s00134-007-0763-3","article-title":"Successful use of extracorporeal membrane oxygenation for severe interstitial lung disease in a child with dermatomyositis.","volume":"33","author":"Zulian","year":"2007","journal-title":"Intensive Care Med"},{"key":"R9-20250502","doi-asserted-by":"crossref","first-page":"577","DOI":"10.1097\/00003246-200203000-00014","article-title":"Extracorporal life support for pulmonary hemorrhage in children: A case series.","volume":"30","author":"Kolovos","year":"2002","journal-title":"Crit Care Med"},{"key":"R10-20250502","doi-asserted-by":"crossref","first-page":"937","DOI":"10.1111\/j.1460-9592.2012.03909.x","article-title":"Extracorporeal membrane oxygenation in a 10-year-old girl with macrophage activation syndrome.","volume":"22","author":"Rossetti","year":"2012","journal-title":"Paediatr Anaesth"},{"key":"R12-20250502","doi-asserted-by":"crossref","first-page":"E99","DOI":"10.1542\/peds.107.6.e99","article-title":"Deaths attributed to pediatric complex chronic conditions: National trends and implications for supportive care services.","volume":"107","author":"Feudtner","year":"2001","journal-title":"Pediatrics"},{"key":"R13-20250502","doi-asserted-by":"crossref","first-page":"199","DOI":"10.1186\/1471-2431-14-199","article-title":"Pediatric complex chronic conditions classification system version 2: Updated for ICD-10 and complex medical technology dependence and transplantation.","volume":"14","author":"Feudtner","year":"2014","journal-title":"BMC Pediatr"},{"key":"R14-20250502","doi-asserted-by":"crossref","first-page":"60","DOI":"10.1097\/MAT.0000000000000475","article-title":"Extracorporeal life support organization registry international report 2016.","volume":"63","author":"Thiagarajan","year":"2017","journal-title":"ASAIO J"},{"key":"R15-20250502","doi-asserted-by":"crossref","first-page":"151","DOI":"10.1177\/0267659116667804","article-title":"Extracorporeal membrane oxygenation outcomes in children with hemophagocytic lymphohistiocytosis.","volume":"32","author":"Cashen","year":"2017","journal-title":"Perfusion"},{"key":"R16-20250502","doi-asserted-by":"crossref","first-page":"364","DOI":"10.1097\/CCM.0b013e3181fb7b35","article-title":"Extracorporeal membrane oxygenation for pediatric respiratory failure: Survival and predictors of mortality.","volume":"39","author":"Zabrocki","year":"2011","journal-title":"Crit Care Med"},{"key":"R17-20250502","doi-asserted-by":"crossref","first-page":"380","DOI":"10.1097\/PCC.0b013e318172d54d","article-title":"Extracorporeal life support for severe respiratory failure in children with immune compromised conditions.","volume":"9","author":"Gupta","year":"2008","journal-title":"Pediatr Crit Care Med"},{"key":"R18-20250502","doi-asserted-by":"crossref","first-page":"1620","DOI":"10.1111\/j.1475-6773.2005.00444.x","article-title":"Measuring diagnoses: ICD code accuracy.","volume":"40","author":"O\u2019Malley","year":"2005","journal-title":"Health Serv Res"}],"container-title":["Pediatric Critical Care Medicine"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/journals.lww.com\/10.1097\/PCC.0000000000002801","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2025,5,2]],"date-time":"2025-05-02T17:32:03Z","timestamp":1746207123000},"score":1,"resource":{"primary":{"URL":"https:\/\/journals.lww.com\/10.1097\/PCC.0000000000002801"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2021,7,14]]},"references-count":17,"journal-issue":{"issue":"1","published-print":{"date-parts":[[2022]]}},"URL":"https:\/\/doi.org\/10.1097\/pcc.0000000000002801","relation":{},"ISSN":["1529-7535"],"issn-type":[{"value":"1529-7535","type":"print"}],"subject":[],"published":{"date-parts":[[2021,7,14]]}}}